Anti-CEP120 monoclonal antibody

Pre-made anti-CEP120 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to CEP120/CEP120 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2873-Ab-1/ GM-Tg-hg-IP2873-Ab-2Anti-Human CEP120 monoclonal antibodyHuman
GM-Tg-rg-IP2873-Ab-1/ GM-Tg-rg-IP2873-Ab-2Anti-Rat CEP120 monoclonal antibodyRat
GM-Tg-mg-IP2873-Ab-1/ GM-Tg-mg-IP2873-Ab-2Anti-Mouse CEP120 monoclonal antibodyMouse
GM-Tg-cynog-IP2873-Ab-1/ GM-Tg-cynog-IP2873-Ab-2Anti-Cynomolgus/ Rhesus macaque CEP120 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2873-Ab-1/ GM-Tg-felg-IP2873-Ab-2Anti-Feline CEP120 monoclonal antibodyFeline
GM-Tg-cang-IP2873-Ab-1/ GM-Tg-cang-IP2873-Ab-2Anti-Canine CEP120 monoclonal antibodyCanine
GM-Tg-bovg-IP2873-Ab-1/ GM-Tg-bovg-IP2873-Ab-2Anti-Bovine CEP120 monoclonal antibodyBovine
GM-Tg-equg-IP2873-Ab-1/ GM-Tg-equg-IP2873-Ab-2Anti-Equine CEP120 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2873-Ab-1/ GM-Tg-hg-IP2873-Ab-2; GM-Tg-rg-IP2873-Ab-1/ GM-Tg-rg-IP2873-Ab-2;
GM-Tg-mg-IP2873-Ab-1/ GM-Tg-mg-IP2873-Ab-2; GM-Tg-cynog-IP2873-Ab-1/ GM-Tg-cynog-IP2873-Ab-2;
GM-Tg-felg-IP2873-Ab-1/ GM-Tg-felg-IP2873-Ab-2; GM-Tg-cang-IP2873-Ab-1/ GM-Tg-cang-IP2873-Ab-2;
GM-Tg-bovg-IP2873-Ab-1/ GM-Tg-bovg-IP2873-Ab-2; GM-Tg-equg-IP2873-Ab-1/ GM-Tg-equg-IP2873-Ab-2
Products NameAnti-CEP120 monoclonal antibody
Formatmab
Target NameCEP120
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-CEP120 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2873-Ag-1Recombinant multi-species CE120/ CEP120/ CCDC100 protein


    Target information

    Target IDGM-IP2873
    Target NameCEP120
    Gene ID153241,225523,307302,701351,474659,101084767,534400,100063918
    Gene Symbol and SynonymsA230075C01,CCDC100,CEP120,JBTS31,RGD1565619,SRTD13
    Uniprot AccessionQ8N960,A0JN62
    Uniprot Entry NameCE120_HUMAN,CE120_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000168944
    Target ClassificationN/A

    The target: CEP120, gene name: CEP120, also named as CCDC100, JBTS31, SRTD13. This gene encodes a protein that functions in the microtubule-dependent coupling of the nucleus and the centrosome. A similar protein in mouse plays a role in both interkinetic nuclear migration, which is a characteristic pattern of nuclear movement in neural progenitors, and in neural progenitor self-renewal. Mutations in this gene are predicted to result in neurogenic defects. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.